You are using an older browser version. Please use a supported version for the best MSN experience.

ACETO CORPORATION

OTC: ACETQ
0.1355
+0.0025
+1.88%

Sector

Healthcare

Industry

Pharmaceuticals

Aceto Corporation is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals and nutraceutical products. The Company's business is organized into the Human Health segment. The Company has presence in China, Germany, France, The Netherlands, Singapore, India, Hong Kong, Philippines, the United Kingdom and the United States. The Human Health segment includes finished dosage form generic drugs and nutraceutical products. The Company supplies the raw materials used in the production of nutritional and packaged dietary supplements, including vitamins, amino acids, iron compounds and biochemicals used in pharmaceutical and nutritional preparations.

Key People

Albert Eilender

Director

William Kennally

President, Chief Executive Officer, Director

Rebecca Roof

Interim Chief Financial Officer

Nicholas Shackley

Senior Vice President - Pharmaceutical Ingredients

Frances Scally

Chief Accounting Officer

  • Aceto Corp

  • 4 Tri Harbor Ct

  • PORT WASHINGTON, NY 11050-4661

  • US.Map

  • Phone: +1 516 6276000

  • Fax: +1 516 6276093

  • aceto.com

Incorporated

1947

Employees

315

Insider Trades
  • Recent
  • All
  • Date

  • Name

  • Transaction

  • Shares

  • Price(s)

  • Value

    • 2/26/2019

    • DEBENEDITTIS FRANK V

    • Sold

    • 47,130

    • 0.14

    • 6,739.59

    • 12/26/2018

    • SCALLY FRANCES P

    • Sold

    • 183

    • 0.91

    • 166.97

    • 10/5/2018

    • DEBENEDITTIS FRANK V

    • Sold

    • 895

    • 2.28

    • 2,040.60

    • 10/4/2018

    • ALAIMO CHARLES JOHN

    • Sold

    • 731

    • 2.37

    • 1,732.40

    • 10/4/2018

    • ALAIMO CHARLES JOHN

    • Grant

    • 1,614

    • 2.33

    • 3,760.62

    • 10/4/2018

    • ROGERS STEVEN

    • Sold

    • 645

    • 2.31

    • 1,492.21

    • 10/4/2018

    • ROGERS STEVEN

    • Grant

    • 1,614

    • 2.33

    • 3,760.62

    • 10/4/2018

    • DEBENEDITTIS FRANK V

    • Grant

    • 1,917

    • 2.33

    • 4,466.61

    • 10/4/2018

    • EILENDER ALBERT L

    • Sold

    • 2,000

    • 2.30

    • 4,600.20

    • 10/4/2018

    • EILENDER ALBERT L

    • Grant

    • 4,641

    • 2.33

    • 10,813.53

    • 9/7/2018

    • EILENDER ALBERT L

    • Sold

    • 10,700

    • 3.29

    • 35,220.12

    • 9/7/2018

    • DEBENEDITTIS FRANK V

    • Sold

    • 2,800

    • 3.33

    • 9,312.24

    • 9/7/2018

    • ROGERS STEVEN

    • Sold

    • 3,769

    • 3.33

    • 12,562.83

    • 9/7/2018

    • KACZMAREK WALTER J. III

    • Sold

    • 6,400

    • 3.33

    • 21,302.40

    • 9/5/2018

    • ALAIMO CHARLES JOHN

    • Sold

    • 3,458

    • 3.29

    • 11,379.24

    • 9/5/2018

    • SCALLY FRANCES P

    • Sold

    • 789

    • 3.29

    • 2,596.36

    • 8/3/2018

    • KACZMAREK WALTER J. III

    • Sold

    • 7,000

    • 3.18

    • 22,294.30

    • 7/5/2018

    • EILENDER ALBERT L

    • Sold

    • 3,800

    • 3.68

    • 13,987.42

    • 7/5/2018

    • DEBENEDITTIS FRANK V

    • Sold

    • 1,170

    • 3.69

    • 4,317.30

    • 7/5/2018

    • ROGERS STEVEN

    • Sold

    • 1,230

    • 3.69

    • 4,538.70

    • Date

    • Name

    • Transaction

    • Shares

    • Price(s)

    • Value

      • 2/26/2019

      • DEBENEDITTIS FRANK V

      • Sold

      • 47,130

      • 0.14

      • 6,739.59

      • 12/26/2018

      • SCALLY FRANCES P

      • Sold

      • 183

      • 0.91

      • 166.97

      • 10/5/2018

      • DEBENEDITTIS FRANK V

      • Sold

      • 895

      • 2.28

      • 2,040.60

      • 10/4/2018

      • ALAIMO CHARLES JOHN

      • Sold

      • 731

      • 2.37

      • 1,732.40

      • 10/4/2018

      • ALAIMO CHARLES JOHN

      • Grant

      • 1,614

      • 2.33

      • 3,760.62

      • 10/4/2018

      • ROGERS STEVEN

      • Sold

      • 645

      • 2.31

      • 1,492.21

      • 10/4/2018

      • ROGERS STEVEN

      • Grant

      • 1,614

      • 2.33

      • 3,760.62

      • 10/4/2018

      • DEBENEDITTIS FRANK V

      • Grant

      • 1,917

      • 2.33

      • 4,466.61

      • 10/4/2018

      • EILENDER ALBERT L

      • Sold

      • 2,000

      • 2.30

      • 4,600.20

      • 10/4/2018

      • EILENDER ALBERT L

      • Grant

      • 4,641

      • 2.33

      • 10,813.53

      • 9/7/2018

      • EILENDER ALBERT L

      • Sold

      • 10,700

      • 3.29

      • 35,220.12

      • 9/7/2018

      • DEBENEDITTIS FRANK V

      • Sold

      • 2,800

      • 3.33

      • 9,312.24

      • 9/7/2018

      • ROGERS STEVEN

      • Sold

      • 3,769

      • 3.33

      • 12,562.83

      • 9/7/2018

      • KACZMAREK WALTER J. III

      • Sold

      • 6,400

      • 3.33

      • 21,302.40

      • 9/5/2018

      • ALAIMO CHARLES JOHN

      • Sold

      • 3,458

      • 3.29

      • 11,379.24

      • 9/5/2018

      • SCALLY FRANCES P

      • Sold

      • 789

      • 3.29

      • 2,596.36

      • 8/3/2018

      • KACZMAREK WALTER J. III

      • Sold

      • 7,000

      • 3.18

      • 22,294.30

      • 7/5/2018

      • EILENDER ALBERT L

      • Sold

      • 3,800

      • 3.68

      • 13,987.42

      • 7/5/2018

      • DEBENEDITTIS FRANK V

      • Sold

      • 1,170

      • 3.69

      • 4,317.30

      • 7/5/2018

      • ROGERS STEVEN

      • Sold

      • 1,230

      • 3.69

      • 4,538.70

      • 7/3/2018

      • ALAIMO CHARLES JOHN

      • Sold

      • 1,457

      • 3.36

      • 4,889.25

      • 7/3/2018

      • SCALLY FRANCES P

      • Sold

      • 601

      • 3.36

      • 2,016.78

      AdChoices
      AdChoices
      AdChoices
      image beaconimage beaconimage beacon